Skip to main content
. 2024 Nov 28;24:515. doi: 10.1186/s12886-024-03774-2

Fig. 4.

Fig. 4

Cross-sectional views of swept-source anterior segment optical coherence tomography (SS-OCT) at 9 months after starting 0.1% tacrolimus eye drops in the right (a) and left (b) eyes, irregularities in the corneal epithelial surface (white arrow) and hyperreflective lesions in the corneal subepithelial region (yellow arrow) were observed. Both issues were resolved at 18 months after starting 0.1% tacrolimus eye drops in the right (c) and left (d) eyes